PREVALENCE OF TOXOPLASMA GONDII INFECTION IN THE WORLD AND SERBIA
Abstract
Toxoplasmosis is one of the most widespread parasitic disease caused by an obligate intracellular protozoan Toxoplasma gondii. It is estimated that one third of the human population is infected with this parasite. In immunocompetent subjects, the infection is mostly asymptomatic or is presented with flu-like symptoms, but in fetus and immunocompromised patients, infection may even be life-threatening. The prevalence of T. gondii infection varies among different countries of the world (0.5 to 87.7%) and within different regions of the same country. In Africa, the prevalence is the highest, in Asia is the lowest, while in Europe, the prevalence of toxoplasmosis ranges from low in the North to moderate in the South of the continent. The worldwide decline in the prevalence of T. gondii infection has been sustained over past few decades. In Serbia, the prevalence of toxoplasmosis tended to increase from the 1960s to the 1980s followed by a dramatic decline after that period, as in the entire Europe. The most prominent decline in the prevalence of T. gondii infection was recorded in the period from 1988 to 2007 in the population of women of reproductive age from 86% to 32.5%. The decreasing tendency of prevalence of toxoplasmosis in Serbia remains continuous even after that period of time, further confirmed by the latest results of research conducted in 2017-2018 in the population of blood donors in Belgrade (20.5% prevalence) and in the general population of Vojvodina during the 2008-2021 period (20% prevalence). Despite the encouraging epidemiological data that indicate the trend of continuous decline in the prevalence of toxoplasmosis in the world and in our country, it is still necessary to conduct additional research to indentify specific risk factors that contribute to the decrease in prevalence of T. gondii infection in the population.
References
1. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30:1217–1258.
2. Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019; 36(4):898-925.
3. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009; 39:1385–94.
4. Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. J Protozool. 1972; 19:155–177.
5. Yan C, Liang L-J, Zheng K-Y, Zhu X-Q. Impact of environmental factors on the emergence, transmission and distribution of Toxoplasma gondii. Parasites Vector. 2016; 9:137.
6. Meerburg, BG, Kijlstra, A. Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res. 2009; 105(1):17-24.
7. Dubey JP . Toxoplasmosis of animals and humans. 2nd ed. Boca Raton:CRC Press; 2010.
8. Patz JA, Graczyk TK, Geller N, Vittor AY. Effects of environmental change on emerging parasitic diseases. Int J Parasitol. 2000; 30:1395-405.
9. Mazzillo FF, Shapiro K, Silver MW. A New Pathogen Transmission Mechanism in the Ocean: The Case of Sea Otter Exposure to the Land-Parasite Toxoplasma gondii. PloS One. 2013; 8:e82477.
10. Ribeiro LA, Santos LK, Brito Jr PA, Maciel BM, Da Silva AV, Albuquerque GR. Detection of Toxoplasma gondii DNA in Brazilian oysters (Crassostrea rhizophorae). Genet Mol Res. 2015; 14:4658-65.
11. Afonso E, Thulliez P, Gilot-Fromont E. Transmission of Toxoplasma gondii in an urban population of domestic cats (Felis catus). Int J Parasitol. 2006; 36(13):1373–1382.
12. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013; 91:501-508.
13. Rostami A, Riahi SM, Contopoulos-Ioannidis DG, Gamble HR, Fakhri Y, Shiadeh MN, et al. Acute Toxoplasma infection in pregnant women worldwide: A systematic review and meta-analysis. PloS Negl Trop Dis. 2019; 13(10):e0007807.
14. Wang ZD, Wang SC, Liu HH, Ma HY, Li ZY, Wei F, et al. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017; 4(4):e177-e188.
15. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012 Apr; 25(2):264-296.
16. Gao XJ, Zhao ZJ, He ZH, Wang T, Yang TB, Chen XG, et al. Toxoplasma gondii infection in pregnant women in China. Parasitology. 2012; 139(2):139-147.
17. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am J Trop Med Hyg. 2007; 77(3):405-410.
18. Rostami A, Riahi SM, Gamble HR, Fakhri Y, Nourollahpour Shiadeh M, Danesh M, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect. 2020 Jun; 26(6), 673–683.
19. Shapiro K, Bahia-Oliveira L, Dixon B, Dumètre A, de Wit LA, VanWormer E, Villena I. Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food. Food Waterborne Parasitol. 2019; 15:e00049.
20. Ferreira FP, Caldart ET, Freire RL, Mitsuka-Breganó R, Freitas FM, Miura AC, et al. The effect of water source and soil supplementation on parasite contamination in organic vegetable gardens. Rev Bras Parasitol Vet. 2018; 27(3):327-337.
21. Fiedler K, Hulsse C, Straube W, Briese V. Toxoplasmosis-antibody seroprevalence in Mecklenburg-Western Pomerania. Zentralbl Gynakol. 1999; 121:239- 243.
22. Zufferey J, Di Mito C, Auckenthaler R. Evaluation of the new Vidia toxoplasmosis IgG and IgM assays in women of childbearing age. Clin Microbiol Infect. 2007; 13(S1):124.
23. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, et al. Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 2010; 15(25):19600.
24. Punda-Polić V, Tonkić M, Capkun V. Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia. Eur J Epidemiol. 2000; 16(9):875–877.
25. Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M. Mlinaric-Galinovic G. Seroprevalence of TORCH infections in women of childbearing age in Croatia. J Matern Fetal Neonatal Med. 2011; 24(2):280–283.
26. Logar J, Novak-Antolič Ž, Zore A. Serological screening for toxoplasmosis in pregnancy in Slovenia. Scand J Infect Dis. 1995; 27(2):163–164.
27. Logar J, Šoba B, Novak-Antolič Ž, Premru-Srsen T, Arnež M, Kraut A. Serological screening for toxoplasmosis of pregnant women in Slovenia in the period 2000–2007. Toxoplasma Centennial Congress: From discovery to public health management; 2008 Sep 20-24; Búzios, Rio de Janeiro State, Brazil; 2008. p.43.
28. Diza E, Frantzidou F, Souliou E, Arvanitidou M, Gioula G, Antoniadis, A. Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years. Clin Microbiol Infect. 2005; 11(9):719–723.
29. Bobić B, Nikolić A, Djurković-Djaković O. Identification of risk factors for infection with Toxoplasma gondii in Serbia as a basis of a programme for prevention of congenital toxoplasmosis. Srp Arh Celok Lek. 2003; 131(3–4):162–167.
30. Bobić B, Nikolić A, Klun I, Vujanić M, Djurkovic–Djakovic O. Undercooked meat consumption remains the major risk factor for Toxoplasma infection in Serbia. Parassitologia. 2007; 49(4):227-230.
31. Stopić M, Štajner T, Marković-Denić Lj, Nikolić V, Djilas I, Srzentić S, et al. Epidemiology of Toxoplasmosis in SERBIA: A Cross-Sectional Study on Blood Donors. Microorganisms. 2022; 10(3):492.
32. Šibalić D, Radović M, Šulović V. Infection par Toxoplasma gondii pendant la grossesse et avant elle et les conséquences possibles sur le foetus. Proceedings of the Second European Multicolloquy of Parasitology; 1975 Sep 1-6; Trogir, Yugoslavia; 1975. p.23-28.
33. Šibalić D. Études sur l’epidemiologie da la toxoplasmose en Serbia. Acta Parasitol. 1980; 11:5-13.
34. Djurković-Djaković O. Toxoplasma infection and pathological outcome of pregnancy. Gynecol Obstet Invest. 1995; 40:36-41.
35. Bobić B, Jevremović I, Marinković J, Šibalić D, Djurković-Djaković O. Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia. Eur J Epidemiol. 1998; 14(6):605-610.
36. Brkić S, Gajski G, Bogavac M, Marić D, Turkulov V, Tomić S. [Seroprevalence of toxoplasmosis in Vojvodina]. Srp Arh Celok Lek. 2010; 138(5-6):333-336.
37. Pribakovic JA, Katanic N, Radevic T, Tasic MS, Kostic M, Stolic B, et al. Serological status of childbearing-aged women for Toxoplasma gondii and cytomegalovirus in northern Kosovo and Metohija. Rev Soc Bras Med Trop. 2019; 17;52:e20170313.
38. Kovačević G, Cvjetković IH, Patić A, Radovanov J, Kovačević, B. Negative trend in seroprevalence of anti-toxoplasma gondii IgG antibodies among the general population of the province of Vojvodina, Serbia, 2008-2021. Parasitol Int. 2023; 92,102689.